Carina Biotech raises $7.5 million at first close with Tenmile as the cornerstone investor

2023-03-07T09:53:40+09:30August 15th, 2022|Uncategorised|

Carina Biotech is extremely pleased to announce that it has raised $7.5 million at first close of its current funding round, welcoming on board new venture capital business Tenmile as

Carina Biotech appoints Cell Therapies to undertake manufacture of LGR5 CAR-T cells for clinical trial

2022-05-31T11:04:59+09:30May 31st, 2022|News, Uncategorised|

Carina Biotech is pleased to announce that it has appointed Australian organisation Cell Therapies to undertake Good Manufacturing Processes (GMP) manufacture of its LGR5 CAR-T cells for a first-in-human clinical

Carina Biotech submits LGR5 CAR-T pre-IND (Investigational New Drug) package to the US Food & Drug Administration

2023-03-07T10:05:20+09:30April 1st, 2022|News, Uncategorised|

Carina Biotech is very pleased to announce that we have submitted a pre-IND (Investigational New Drug) application to the US FDA (Food & Drug Administration) for our CAR-T therapy that targets a

Carina Biotech licenses German technology to create highly efficient CAR-T cells targeting hard-to-treat cancers

2023-03-07T10:05:36+09:30December 15th, 2021|News, Uncategorised|

Carina Biotech has entered a license agreement with Bayerische Patentallianz (BayPAT) to the CXCR6-transduced CAR-T cell technology developed at the University Hospital of Ludwig-Maximillian University of Munich (LMU). The agreement

Carina research scientist finishes two-month stint at Seattle Children’s Research Institute

2023-03-07T10:07:53+09:30May 14th, 2019|Uncategorised|

Jade Foeng, research scientist and PhD student from the McColl lab at the University of Adelaide, has finished up a two-month stint at Seattle Children's Research Institute Seattle Children's in the

Go to Top